| Application no. and date | 02028325.5 (espacenet) (Federated) (European Patent Register), 19971128 | | Patent/reg. no. and date | DK/EP 1310243, 20070808 | | Publication date | 20030514 | | Priority no. and date | SE 9604486, 19961205, US 846960, 19970429 | | EP pub. no. and date |
EP 1310243 20030514 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | A1591-2X EP | | Inventor | Santesson, Gordon, Anemongatan 6
242 34 Hörby, SE,
Nilsson, Hans, AstraZeneca R&D Lund
221 87 Lund, SE | | Representative | | | Opponent | | | IPC Class | A61K 31/58 (2006.01) , A61K 9/00 (2006.01) , A61K 9/10 (2006.01) , A61P 11/02 (2006.01) | | Title | Hidtil ukendt formulering, som omfatter budesonid | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
